Lluı́s Samaranch

3.2k total citations
49 papers, 2.2k citations indexed

About

Lluı́s Samaranch is a scholar working on Genetics, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Lluı́s Samaranch has authored 49 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Genetics, 19 papers in Cellular and Molecular Neuroscience and 17 papers in Molecular Biology. Recurrent topics in Lluı́s Samaranch's work include Virus-based gene therapy research (15 papers), Parkinson's Disease Mechanisms and Treatments (13 papers) and Nerve injury and regeneration (8 papers). Lluı́s Samaranch is often cited by papers focused on Virus-based gene therapy research (15 papers), Parkinson's Disease Mechanisms and Treatments (13 papers) and Nerve injury and regeneration (8 papers). Lluı́s Samaranch collaborates with scholars based in United States, Spain and France. Lluı́s Samaranch's co-authors include Krystof S. Bankiewicz, Waldy San Sebastián, John Forsayeth, Adrian P. Kells, Ernesto A. Salegio, John R. Bringas, Pau Pástor, John R. Bringas, Oswaldo Lorenzo‐Betancor and María A. Pastor and has published in prestigious journals such as Nature Medicine, PLoS ONE and Brain.

In The Last Decade

Lluı́s Samaranch

49 papers receiving 2.2k citations

Peers

Lluı́s Samaranch
Liang‐Fong Wong United Kingdom
Hussein Daoud Canada
Er‐Yun Chen United States
Ida E. Holm Denmark
Laura Canafoglia Italy
Alexander Zimprich Austria
Paymaan Jafar‐Nejad United States
Kunihiko Ikeguchi Japan
Waldy San Sebastián United States
G. Ralph United Kingdom
Liang‐Fong Wong United Kingdom
Lluı́s Samaranch
Citations per year, relative to Lluı́s Samaranch Lluı́s Samaranch (= 1×) peers Liang‐Fong Wong

Countries citing papers authored by Lluı́s Samaranch

Since Specialization
Citations

This map shows the geographic impact of Lluı́s Samaranch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lluı́s Samaranch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lluı́s Samaranch more than expected).

Fields of papers citing papers by Lluı́s Samaranch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lluı́s Samaranch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lluı́s Samaranch. The network helps show where Lluı́s Samaranch may publish in the future.

Co-authorship network of co-authors of Lluı́s Samaranch

This figure shows the co-authorship network connecting the top 25 collaborators of Lluı́s Samaranch. A scholar is included among the top collaborators of Lluı́s Samaranch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lluı́s Samaranch. Lluı́s Samaranch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ford, Matthew M., Victor S. Van Laar, Katherine M. Holleran, et al.. (2023). GDNF gene therapy for alcohol use disorder in male non-human primates. Nature Medicine. 29(8). 2030–2040. 12 indexed citations
2.
Samaranch, Lluı́s, Vivek Sudhakar, Jerónimo Jurado‐Arjona, et al.. (2019). Adeno-associated viral vector serotype 9–based gene therapy for Niemann-Pick disease type A. Science Translational Medicine. 11(506). 34 indexed citations
3.
Samaranch, Lluı́s, Kousaku Ohno, Waldy San Sebastián, & Krystof S. Bankiewicz. (2019). Cerebellomedullary Cistern Injection of Viral Vectors in Nonhuman Primates. Methods in molecular biology. 1937. 313–324. 2 indexed citations
4.
Díez-Fairén, Mónica, Bruno A. Benítez, Sara Ortega‐Cubero, et al.. (2018). Pooled-DNA target sequencing of Parkinson genes reveals novel phenotypic associations in Spanish population. Neurobiology of Aging. 70. 325.e1–325.e5. 3 indexed citations
5.
Nagahara, Alan H., Bayard Wilson, Iryna Ivasyk, et al.. (2018). MR-guided delivery of AAV2-BDNF into the entorhinal cortex of non-human primates. Gene Therapy. 25(2). 104–114. 43 indexed citations
6.
Samaranch, Lluı́s, Bas Blits, Waldy San Sebastián, et al.. (2017). MR-guided parenchymal delivery of adeno-associated viral vector serotype 5 in non-human primate brain. Gene Therapy. 24(4). 253–261. 61 indexed citations
7.
Samaranch, Lluı́s, et al.. (2016). Axonal transport of AAV9 in nonhuman primate brain. Gene Therapy. 23(6). 520–526. 41 indexed citations
8.
Hadaczek, Piotr, Lisa M. Stanek, Agnieszka Ciesielska, et al.. (2016). Widespread AAV1- and AAV2-mediated transgene expression in the nonhuman primate brain: implications for Huntington's disease. Molecular Therapy — Methods & Clinical Development. 3. 16037–16037. 33 indexed citations
9.
Samaranch, Lluı́s, Piotr Hadaczek, Adrian P. Kells, et al.. (2015). Slow AAV2 clearance from the brain of nonhuman primates and anti-capsid immune response. Gene Therapy. 23(4). 393–398. 6 indexed citations
10.
Passini, Marco A., Jie Bu, Amy M. Richards, et al.. (2014). Translational Fidelity of Intrathecal Delivery of Self-Complementary AAV9–Survival Motor Neuron 1 for Spinal Muscular Atrophy. Human Gene Therapy. 25(7). 619–630. 72 indexed citations
11.
Sebastián, Waldy San, Adrian P. Kells, John R. Bringas, et al.. (2014). Safety and tolerability of MRI-guided infusion of AAV2-hAADC into the mid-brain of nonhuman primate. Molecular Therapy — Methods & Clinical Development. 1. 14049–14049. 27 indexed citations
12.
Sebastián, Waldy San, Lluı́s Samaranch, Gregory Heller, et al.. (2013). Adeno-associated virus type 6 is retrogradely transported in the non-human primate brain. Gene Therapy. 20(12). 1178–1183. 45 indexed citations
13.
Salegio, Ernesto A., Lluı́s Samaranch, Russell W. Jenkins, et al.. (2012). Safety Study of Adeno-Associated Virus Serotype 2-Mediated Human Acid Sphingomyelinase Expression in the Nonhuman Primate Brain. Human Gene Therapy. 23(8). 891–902. 19 indexed citations
14.
Botta‐Orfila, Teresa, Mario Ezquerra, Pau Pástor, et al.. (2012). Age at Onset in LRRK2-Associated PD is Modified by SNCA Variants. Journal of Molecular Neuroscience. 48(1). 245–247. 27 indexed citations
15.
Lorenzo‐Betancor, Oswaldo, Lluı́s Samaranch, Mario Ezquerra, et al.. (2011). LRRK2 haplotype‐sharing analysis in Parkinson's disease reveals a novel p.S1761R mutation. Movement Disorders. 27(1). 146–150. 15 indexed citations
16.
Lorenzo‐Betancor, Oswaldo, Lluı́s Samaranch, Elena Garcı́a-Martı́n, et al.. (2011). LINGO1 gene analysis in Parkinson's disease phenotypes. Movement Disorders. 26(4). 722–727. 15 indexed citations
17.
Samaranch, Lluı́s, Oswaldo Lorenzo‐Betancor, José Matías Arbelo, et al.. (2010). PINK1-linked parkinsonism is associated with Lewy body pathology. Brain. 133(4). 1128–1142. 187 indexed citations
18.
Cruchaga, Carlos, María A. Fernández‐Seara, Manuel Seijo‐Martínez, et al.. (2008). Cortical Atrophy and Language Network Reorganization Associated with a Novel Progranulin Mutation. Cerebral Cortex. 19(8). 1751–1760. 36 indexed citations
19.
Blázquez, Lorea, David Juan, Javier Ruiz‐Martínez, et al.. (2006). Genes related to iron metabolism and susceptibility to Alzheimer's disease in Basque population. Neurobiology of Aging. 28(12). 1941–1943. 26 indexed citations
20.
Ribé, Elena M., Mar Pérez, Berta Puig, et al.. (2005). Accelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP/tau transgenic mice. Neurobiology of Disease. 20(3). 814–822. 128 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Liang‐Fong Wong Breakdown of academic impact, for papers by Hussein Daoud Breakdown of academic impact, for papers by Er‐Yun Chen Breakdown of academic impact, for papers by Ida E. Holm Breakdown of academic impact, for papers by Laura Canafoglia Breakdown of academic impact, for papers by Alexander Zimprich Breakdown of academic impact, for papers by Paymaan Jafar‐Nejad Breakdown of academic impact, for papers by Kunihiko Ikeguchi Breakdown of academic impact, for papers by Waldy San Sebastián Breakdown of academic impact, for papers by G. Ralph
Rankless by CCL
2026